Yüzen Dennis, Urbschat Christopher, Schepanski Steven, Thiele Kristin, Arck Petra C, Mittrücker Hans-Willi
Division of Experimental Feto-Maternal Medicine, Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
EMBO Rep. 2023 Oct 9;24(10):e56829. doi: 10.15252/embr.202356829. Epub 2023 Aug 23.
Neonatal health is determined by the transfer of maternal antibodies from the mother to the fetus. Besides antibodies, maternal cells cross the placental barrier and seed into fetal organs. Contrary to maternal antibodies, maternal microchimeric cells (MMc) show a high longevity, as they can persist in the offspring until adulthood. Recent evidence highlights that MMc leukocytes promote neonatal immunity against early-life infections in mice and humans. As shown in mice, this promotion of immunity was attributable to an improved fetal immune development. Besides this indirect effect, MMc may be pathogen-specific and thus, directly clear pathogen threats in the offspring postnatally. By using ovalbumin recombinant Listeria monocytogenes (LmOVA), we here provide evidence that OVA-specific T cells are transferred from the mother to the fetus, which is associated with increased activation of T cells and a milder course of postnatal infection in the offspring. Our data highlight that maternally-derived passive immunity of the neonate is not limited to antibodies, as MMc have the potential to transfer immune memory between generations.
新生儿健康取决于母体抗体从母亲向胎儿的转移。除了抗体,母体细胞会穿过胎盘屏障并植入胎儿器官。与母体抗体不同,母体微嵌合细胞(MMc)具有很长的寿命,因为它们可以在后代体内持续存在直至成年。最近的证据表明,MMc白细胞可促进小鼠和人类新生儿对早期感染的免疫。如在小鼠中所示,这种免疫促进作用归因于胎儿免疫发育的改善。除了这种间接作用外,MMc可能具有病原体特异性,因此可在产后直接清除后代体内的病原体威胁。通过使用卵清蛋白重组单核细胞增生李斯特菌(LmOVA),我们在此提供证据表明,OVA特异性T细胞从母亲转移至胎儿,这与后代T细胞的激活增加以及产后感染病程较轻有关。我们的数据突出表明,新生儿的母体来源被动免疫并不局限于抗体,因为MMc有潜力在代际之间传递免疫记忆。